skip to Main Content

Submitted Case

2024
1. Submitted Case
2. Submitted Case
3. Submitted Case
4. Submitted Case
5. Submitted Case
6. Submitted Case
7. Submitted Case
8. Submitted Case
9. Submitted Case
10. Submitted Case
11. Submitted Case
Patient Information: (Do not provide name of the patient)
Age
  67
Diagnosis
  recurrent endometrial cancer at R vaginal cuff. 2016 TAH/BSO: T1aNx Endometrioid adenocarcinoma, FIGO grade 2. 1.8 cm confined to endometrium. LVS-, margins-.
Imaging
  CT: 3.9cm mass arising from R vag cuff, causing R hydroureter. MRI pending.
Pathology
  3/7/24 VAGINAL MASS Bx: Recurrent/metastatic endometrioid adenocarcinoma. The carcinoma consists of solid sheets of cells with moderate nuclear pleomorphism present beneath squamous mucosa. IHC is positive for ER and PAX8 with no overexpression of p53 or p16, consistent with an endometrioid adenocarcinoma.
Stage
  no nodal mets, no distant mets
Overall Oncology Management Plan
Chemotherapy (if given, what is the regimen)
  weekly cisplatin
Radiation Therapy (fields, dose)
  50.4Gy to pelvis nodes and recurrent 3.9cm R vag cuff tumor mass, followed by interstitial vs IMRT boost
Radiation Treatment Plan
Normal Tissue Sparing
  tumor abuts small bowel loops, dose limits to small bowel?
Images
Upload Image
 
 
 
 
 
Session Name
  GYN Specialist Dr. Christine Fisher – May 9, 2024
Session ID
  13792
created_by
  6949
post_id
  13792
Back To Top